Tag: business news

Trump set to talk to Russia’s Putin ‘very soon’ about plague-related death in Siberia

Posted on By Admin No Comments on Trump set to talk to Russia’s Putin ‘very soon’ about plague-related death in Siberia

US President Donald Trump speaks to members of the media on the South Lawn of the White House after arriving on Marine One in Washington, DC, US, on Tuesday, Oct. 6, 2026. Trump said he has a call scheduled with Russian President Vladimir Putin to discuss a suspected plague case, amid growing global health concerns over the incident….

Read More “Trump set to talk to Russia’s Putin ‘very soon’ about plague-related death in Siberia” »

Health

Trump administration removes around 760,000 Obamacare enrollments, alleging fraud

Posted on By Admin No Comments on Trump administration removes around 760,000 Obamacare enrollments, alleging fraud

An Obamacare sign is displayed outside an insurance agency on Nov. 12, 2025, in Miami. Joe Raedle | Getty Images News | Getty Images The Centers for Medicare and Medicaid Services said on Tuesday it canceled roughly 315,000 Affordable Care Act marketplace enrollments covering about 760,000 people last month, alleging unauthorized enrollments, characterized by Vice…

Read More “Trump administration removes around 760,000 Obamacare enrollments, alleging fraud” »

Health

A rare disease is taking his vision. A gene therapy could help — if he can get it

Posted on By Admin No Comments on A rare disease is taking his vision. A gene therapy could help — if he can get it

Judy and Courtney Stecker with their sons, Read (left) and Wheeler (right). Judy and Courtney Stecker CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance research, innovation and patient care in rare diseases. If any parents should be able to help their sick child,…

Read More “A rare disease is taking his vision. A gene therapy could help — if he can get it” »

Health

FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients

Posted on By Admin No Comments on FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients

The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday.  The drug, marketed as Bixlenvo, is aimed at patients whose virus is already under control but who remain on complicated treatment regimens. It could also appeal to those who simply want…

Read More “FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients” »

Health

Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline

Posted on By Admin No Comments on Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline

Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart drug trial failed to reduce major adverse cardiovascular events, or MACE, compared to a placebo. While the experimental medicine, ziltivekimab, did show some biological effect, it didn’t translate into a statistically meaningful reduction in MACE, defined as…

Read More “Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline” »

Health

Fat cat? Weight-loss drugs may be coming for your overweight pet

Posted on By Admin No Comments on Fat cat? Weight-loss drugs may be coming for your overweight pet

A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet. Ryersonclark | E+ | Getty Images Felix is five years old, loves food, and refuses to lose weight. His owner, Amy in Dallas, has tried cutting back on meals, but with two cats in the house, “he just gobbles…

Read More “Fat cat? Weight-loss drugs may be coming for your overweight pet” »

Health

Jim Cramer says this former Covid market darling is finally investable again

Posted on By Admin No Comments on Jim Cramer says this former Covid market darling is finally investable again

Moderna’s expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic, CNBC’s Jim Cramer said Wednesday. “For the first time in a long time, the company seems like it has something to get excited about,” the “Mad Money” host said, before advising…

Read More “Jim Cramer says this former Covid market darling is finally investable again” »

Health

UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency

Posted on By Admin No Comments on UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency

Thomas Fuller | SOPA Images | Lightrocket | Getty Images UniQure plans to seek FDA approval of its experimental gene therapy for Huntington’s disease, the company said Wednesday, months after previous agency leaders criticized the evidence backing the application. UniQure said the FDA in a recent meeting communicated that a three-year analysis from a Phase…

Read More “UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency” »

Health

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

Posted on By Admin No Comments on AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout the research process. “The value of AI in our industry is productivity improvement,” Soriot said on CNBC’s “Mad Money” on Friday. “In the way you design a new medicine, a new drug, you can actually do it…

Read More “AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success” »

Health